Model (1) | Model (2) | Model (3) | Model (4 A) | Model (4B) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
Age (years) | 1.032 (1.03–1.04) | < 0.001 | 1.028 (1.02–1.03) | < 0.001 | 1.028 (1.02–1.03) | < 0.001 | 1.022 (1.02–1.03) | < 0.001 | 1.02 (1.02–1.02) | < 0.001 |
Gender (Female vs. Male) | 1.131 (1.03–1.24) | 0.009 | 1.176 (1.07–1.29) | 0.001 | 1.138 (1.04–1.25) | 0.007 | 0.892 (0.81–0.99) | 0.027 | 0.87 (0.79–0.96) | 0.007 |
Resting heart rate (bpm) | 1.002 (1.00–1.00) | 0.109 | 1.003 (1.00-1.01) | 0.011 | 1.004 (1.00-1.01) | 0.003 | 1.002 (1.00-1.01) | 0.109 | 1.001 (1.00–1.00) | 0.452 |
Cardiovascular risk factors | ||||||||||
Hypertension | 1.189 (1.08–1.31) | < 0.001 | 1.138 (1.03–1.26) | 0.015 | 1.06 (0.95–1.18) | 0.284 | 1.059 (0.95–1.18) | 0.293 | ||
Hyperlipidemia | 1.196 (1.08–1.32) | < 0.001 | 1.502 (1.36–1.66) | < 0.001 | 1.537 (1.39–1.70) | < 0.001 | 1.539 (1.39–1.71) | < 0.001 | ||
Smoking | 1.202 (0.94–1.54) | 0.150 | 1.241 (0.97–1.59) | 0.090 | 1.19 (0.93–1.52) | 0.167 | 1.178 (0.92–1.51) | 0.193 | ||
Lung disease | 1.06 (0.77–1.46) | 0.720 | 0.961 (0.69–1.34) | 0.814 | 0.94 (0.67–1.31) | 0.716 | 0.908 (0.65–1.27) | 0.572 | ||
Known CAD | 1.154 (0.98–1.36) | 0.092 | 1.149 (0.97–1.37) | 0.117 | 1.18 (0.99–1.40) | 0.060 | 1.189 (1.00-1.41) | 0.049 | ||
Known CHF | 0.588 (0.36–0.97) | 0.039 | 0.483 (0.29–0.81) | 0.005 | 0.431 (0.26–0.72) | 0.001 | 0.429 (0.26–0.71) | 0.001 | ||
Medications | ||||||||||
Statins | 0.332 (0.28–0.40) | < 0.001 | 0.338 (0.28–0.41) | < 0.001 | 0.338 (0.28–0.41) | < 0.001 | ||||
PPI | 1.632 (1.32–2.01) | < 0.001 | 1.563 (1.27–1.93) | < 0.001 | 1.568 (1.27–1.94) | < 0.001 | ||||
CCB | 0.994 (0.81–1.21) | 0.955 | 1.005 (0.82–1.23) | 0.964 | 0.999 (0.82–1.22) | 0.993 | ||||
BB | 1.697 (1.38–2.09) | < 0.001 | 1.615 (1.31–1.99) | < 0.001 | 1.588 (1.29–1.96) | < 0.001 | ||||
ACE/ARB | 0.996 (0.86–1.15) | 0.951 | 0.979 (0.85–1.13) | 0.771 | 0.988 (0.86–1.14) | 0.866 | ||||
Diuretic | 1.187 (0.95–1.48) | 0.124 | 1.182 (0.95–1.47) | 0.138 | 1.164 (0.93–1.45) | 0.178 | ||||
METs (Categories) | ||||||||||
METs 6–9 | 0.871 (0.75–1.01) | 0.073 | ||||||||
METs 10–11 | 0.619 (0.52–0.73) | < 0.001 | ||||||||
METs ≥ 12 | 0.482 (0.39–0.59) | < 0.001 | ||||||||
METs (Continuous) | 0.90 (0.88–0.92) | < 0.001 | ||||||||
Chronotropic incompetence | 1.119 (1.01–1.24) | 0.030 | 1.056 (0.95–1.17) | 0.303 | ||||||
Duke Risk Score | ||||||||||
High Risk | 1.293 (1.00-1.67) | 0.048 | 1.257 (0.97–1.62) | 0.078 | ||||||
Moderate Risk | 1.26 (1.14–1.39) | < 0.001 | 1.21 (1.10–1.33) | < 0.001 |